Innovation in the Faculty of Medicine



In the news:

'We're really close': U of T expert on Toronto becoming a leading health innovation hub

Celebrating U of T health innovation

H2i Health Innovation Hub
H2i was established to create a culture and infrastructure that aligns, connects, serves and facilitates student driven translation of discoveries and ideas into problem-solving designs that impact positively on health matters. This mission of H2i is to enable, collaborate, educate, and facilitate student initiated commercialization of health matters.

In the news: 

Restorative Breast Cancer Solution Start-Up Wins the 2018 FACIT Pitch Competition
Two H2I client companies – Xpan and 16 Bit – take top prizes at RBC Innovation & Entrepreneurship awards
H2i venture ImmunoBiochem Corporation enters into collaboration with advanced Proteome Therapeutics to develop improved ADCs
U of T startups take home prizes at health challenge event
Medical startups compete for $15,000 in prizes at U of T accelerator's pitch event

Innovation machine: How one U of T researcher is having an outsized impact on the health startup space
H2i Spotlight: Nutartniq
U of T health accelerator H2i breaks down 'walls' with innovation-focused networking event



CCDR Centre for Collaborative Drug Research
A multidisciplinary initiative bringing together the Faculty of Medicine, the Leslie Dan Faculty of Pharmacy and the Centre for Addiction and Mental Health, the CCDR is designed to spur networking, collaboration and innovation in drug research. The CCDR is actively involved in developing new models for collaboration and innovation with the pharmaceutical industry and other partners. The Centre’s initial areas of research focus include: New Targets in Neuroscience, Natural Products in Health & Disease, Pharmacogenomics & Drug Safety, and New Approaches to Anti-infective Therapy. 

CCRM Centre for Commercialization of Regenerative Medicine
Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and bioengineers have come together to form CCRM. CCRM’s mission is to generate sustainable health and economic benefits through global collaboration in cell and gene therapy, and regenerative medicine. 

CCAB Centre for Commercialization in Antibodies and Biologics
CCAB translates early stage biologics into high-value assets and products. Partners can access a robust portfolio of validated antibodies and biologics, powered by the University of Toronto’s antibody discovery engine, the Toronto Recombinant Antibody Centre (TRAC). From discovery and development to validation and licensing, CCAB reduces the time, risk, and costs associated with bringing new antibodies to market.


TBEP Translational Biology and Engineering Program
TBEP is the University of Toronto’s component of the Ted Rogers Centre for Heart Research (TRCHR). Occupying the 14th floor of MaRS Discovery District’s West Tower, TBEP brings together eight faculty members and their students from U of T Dentistry, Engineering and Medicine to advance heart research, diagnostics, and regeneration using a comprehensive approach that includes systems and developmental biology, technology innovation and clinical translation.

IBBME Institute of Biomaterials & Biomedical Engineering
IBBME researchers collaborate across the disciplines of engineering, medicine and dentistry to develop innovative solutions for the most pressing health-care challenges in the world. Learn about their four research themes in biomedical and clinical engineering that are shaping the next frontiers in human health.


Innovation Partners and Resources

Banting & Best Innovation for Entrepreneurship

University of Toronto Innovation and Partnerships

MaRS Innovation

Back to Top